MIF and visceral leishmaniasis: In this study, we evaluated a vaccine against visceral leishmaniasis consisting of a double genetically deficient Leishmania donovani for the Centrin 1 gene and macrophage migration inhibitory factor (LdCen−/−MIF−/−).